BioSpace News Archive

Centene Corporation (NYSE: CNC) today announced that it has completed its acquisition of PANTHERx, one of the largest and fastest-growing specialty pharmacies in the United States specializing in orphan drugs and treating rare diseases. “We are pleased to welcome the PANTHERx team to the Centene family,” said Michael F. Neido

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it has selected ARCT-032, an aerosolized LUNAR® mRNA-based therapeutic candidate, as a development candidate for Cystic Fibrosis (CF), a prog

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI) , a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announces that the Company has received a written response from the U.S. Food & Drug Administration (“FDA”) to its Request for Information in accordance with Section 513(g) of the U.S. Federal Food, Drug and Cosmetic Act (“FD&am

New Global Industry Coalition That Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, is pleased to announce that upon paying US$3,171,540 on December 24, 2020, it has made the final payment in connection with the previously announced acquisition of all of the assets of Neuro-Pro Monitoring.

Expands physician and patient access to Biocept’s Target Selector™ liquid biopsy testing for the management of patients diagnosed with cancer

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 16, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Glenn David will review fourth quarter and full year 2020 financial results and respond to questions from financial analysts during the call. Investors and the public may access the live webcast by visiting the Z

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that a Marketing Authorization Application has been submitted by its agents in Mexico to Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), the health regulatory authority for Mexico, for its COVI-STIX rapid diagnostic test for the detection of the SARS-CoV-2 virus nucleocapsid antigen in nasal samples of patients,

AIM Laboratories, a locally owned and operated diagnostics lab that has performed more than 250,000 COVID-19 tests to date, announced a new program to support St. Louis area schools and businesses that will begin in 2021.

Walgreens Boots Alliance, Inc. announced that Co-Chief Operating Officer Alex Gourlay and Executive Vice President and Global Chief Financial Officer James Kehoe will participate at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 13 at 11:40 a.m. Eastern time.